This article will take you 2 minute(s) to read
Joyance Partners, a venture capital partnership that invests in early-stage companies announced its expansion into Europe recently. Founded by William Lohse in 2017, the VC Firm has made over 50 investments related to the emerging science of health and happiness. Joyance focuses on emerging science and technology with the potential to deliver these uplifting experiences.
“We’re extremely pleased with the companies we’ve seen in the US and are excited to expand our search for companies that contribute to individual health and happiness to Europe,” said Mike Edelhart, Managing Partner of Joyance Partners.
Moreover, Joyance EU will work actively with universities, government organizations, accelerators, angel networks, and venture funds to uncover Europe’s future powerhouses — in Genetics, Bio, Neuro, Microbiome, VR/AR, and much more.
To lead the fund, Joyance Partners has appointed Paolo Pio as Managing Director of Joyance Partners Europe. “The European startup scene is growing rapidly, and it needs funds like Joyance to provide the kind of support and capital necessary at the very early stages,” said Paolo
Furthermore, to support the fund’s growth, two additional team members have been brought on: Holly Jacobus (Investment Partner, NY) and Jun Deng, PhD (Investment Partner, Silicon Valley). Europe has the deep science and educational richness to become a central source for companies globally that enable and create delightful moments.
“We have been gratified that the first year of investment for Joyance US resulted in so many strong, young portfolio companies, some still at the lab stage, pioneering new science that can dramatically improve health and longevity — and with those improvements, expand personal happiness,” said Mike Edelhart. “We’re eager to bring our unique moment-of-inception investment approach to Europe.”
Stock photo from William Perugini/Shutterstock
Stay tuned to Silicon Canals for more updates in the tech startup world.